Description
Discover the power of Spnib 50mg Tablet, an essential treatment option for Chronic Myeloid Leukemia (CML) and Ph+ acute lymphoblastic leukemia. Each tablet is formulated with DASATINIB, a potent active ingredient that targets and helps control the proliferation of abnormal white blood cells caused by the Philadelphia chromosome alteration. Suitable for both adults and children over one year of age, Spnib is particularly effective for those newly diagnosed with Philadelphia chromosome-positive (Ph+) CML in the chronic phase or patients who have shown resistance to other therapies. Choose Spnib 50mg Tablet to take a proactive step in managing your health and combating leukemia with confidence.
Related Products
Lucirux Ruxolitinib 5 mg Tablet
Molecule: Ruxolitinib
Manufacturer: Lucius Pharma
Ask for Price
Enquiry Form
Related Posts:
No matching posts found.
Reviews
Clear filtersThere are no reviews yet.